María Teresa Curiel García

Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962)

J.M. Piulats Rodriguez, Luis de la Cruz‐Merino, Enrique Espinosa et al. · Annals of Oncology · 2018 · 33 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Phase II multicenter, single arm, open label study of nivolumab (NIVO) in combination with ipilimumab (IPI) as first line in adult patients (pts) with metastatic uveal melanoma (MUM): GEM1402 NCT02626962.

Josep M. Piulats, Luis de la Cruz‐Merino, María Teresa Curiel García et al. · Journal of Clinical Oncology · 2017 · 15 citations

Medicine, Oncology, Pharmacotherapy +17

Phase II multicenter study of imatinib in patients with chemorefractory germ cell tumors that express c-kit.

JM Piulats, Xavier García del Muro, Robert Huddart et al. · Cancer Research · 2007 · 12 citations

Medicine, Oncology, Pharmacology +12